Ticker · CUSIP 75629V104

RXRX

RECURSION PHARMACEUTICALS IN
···Share
Holders (tracked)
12
Combined shares
80,887,987
Combined value
$329.13M
Last close
$3.60
Quarter
2025Q4
Tracked holders · last 8 quarters
+3 vs previous quarter over the last 8.
12132024Q12025Q4
Price is -11.5% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

21 events
  1. −14,910 shares · 2025Q4
    13F
  2. +2,881,315 shares · 2025Q4
    13F
  3. +89,544 shares · 2025Q4
    13F
  4. +624,318 shares · 2025Q4
    13F
  5. +1,495,839 shares · 2025Q4
    13F
  6. +654,211 shares · 2025Q4
    13F
  7. +96,479 shares · 2025Q4
    13F
  8. −661 shares · 2025Q4
    13F
  9. +3,771,357 shares · 2025Q4
    13F
  10. +5,739,064 shares · 2025Q4
    13F
  11. −203,723 shares · 2025Q4
    13F
  12. +1,282,992 shares · 2025Q3
    13F
  13. −633,403 shares · 2025Q3
    13F
  14. +1,010 shares · 2025Q3
    13F
  15. −739,408 shares · 2025Q3
    13F
  16. +37,217 shares · 2025Q3
    13F
  17. +58,295 shares · 2025Q3
    13F
  18. −3,169,938 shares · 2025Q3
    13F
  19. +1,625,261 shares · 2024Q3
    13F
  20. +556,868 shares · 2025Q3
    13F
  21. −195,120 shares · 2025Q3
    13F

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of RXRX…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2021Q2$1.13+217.7%$1.5M
Ken Griffin (Citadel Advisors)2021Q2$4.55-20.8%$7.1M
Ken Griffin (Citadel Advisors)2021Q2$4.55-20.8%$7.1M
Ken Griffin (Citadel Advisors)2021Q2$4.55-20.8%$7.1M
Izzy Englander (Millennium Mgmt)2021Q4$4.69-23.2%$5.4M
D.E. Shaw & Co.2023Q1$5.15-30.1%$322K
Two Sigma Investments2022Q1$5.91-39.1%$11.1M
Wellington Management2024Q3$5.92-39.2%$549K
Steve Cohen (Point72)2023Q3$7.50-52.0%$2.4M
Cathie Wood (ARK Invest)2021Q2$9.21-60.9%$134.3M
Baillie Gifford & Co2021Q2$28.35-87.3%$85.6M
Norges Bank (Norway SWF)2021Q2$1306.62-99.7%$20.7M

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions4
Added to4
Trimmed2
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
12
$10.25B
2022Q2
11
$34.91B
2022Q3
11
$46.9M
2022Q4
12
$348.6M
2023Q1
13
$297.7M
2023Q2
11
$337.0M
2023Q3
14
$370.3M
2023Q4
11
$621.3M
2024Q1
13
$661.1M
2024Q2
10
$578.0M
2024Q3
11
$424.7M
2024Q4
9
$452.4M
2025Q1
11
$347.0M
2025Q2
12
$337.6M
2025Q3
9
$314.9M
2025Q4
12
$329.1M

Who owns RXRX

12 super-investors · 2025Q4
Tracked stake
80.89M
shares
Combined value
$329M
% of shares outstanding
shares-out unknown
Quarter action mix
New4Added6Trim2
#ManagerSharesValue
1Cathie Wood
ARK Invest
37.32M$153M
2Baillie Gifford & Co23.77M$97M
3Norges Bank
Norway SWF
5.74M$23M
4Ken Griffin
Citadel Advisors
4.23M$17M
5Two Sigma Investments3.08M$13M
6Ken Griffin
Citadel Advisors
1.98M$8M
7Ken Griffin
Citadel Advisors
1.97M$8M
8Izzy Englander
Millennium Mgmt
1.50M$6M
9Steve Cohen
Point72
654.2K$3M
10Wellington Management152.6K$624K
11D.E. Shaw & Co.89.5K$366K
12T. Rowe Price415.4K$2K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live RXRX chart.
<iframe src="https://openstocks.me/embed/stock/RXRX" width="100%" height="480" frameborder="0" loading="lazy" title="RXRX chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>